Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The aim of this prospective, non-randomised, open-label, clinical trial is to compare the
effects of two pituitary suppression regimens; GnRH Agonist-Long Protocol and GnRH
Antagonist-Flexible Protocol on clinical and embryological IVF/ICSI outcomes, and on the
follicular fluid levels of Placental Growth Factor (PlGF); which is known for his pivotal
role in the regulation of ovulation, embryo development, and implantation.